Swift Biosciences

The sample prep technologies firm intends to use the funding to expand its commercial channels, among other things.

A team from Mount Sinai and Swift Biosciences used targeted sequencing to detect cancer mutations in uterine lavage fluid.

The partners plan to improve yields from small input samples and provide better sequencing libraries.

Both partners believe the agreement will help expand the scope of their services and give them additional markets for their products.  

The companies will combine their technologies to create workflows for the next-generation sequencing of tumor cells obtained from FFPE samples. 

The companies are combining their respective products to provide a solution that covers genetic testing from sample prep to clinical reports.

Swift will incorporate Horizon Discovery's NGS reference standards as a positive control in its oncology panel.

Researchers hope that newfound genetic information will help conservation efforts for the vaquita porpoise. 

The jointly developed workflow uses Fluxion's IsoFlux system for circulating tumor cell enrichment along with Swift's Accel-Amplicon technology.

Pages

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.